NEWS & EVENTS | OSLO UNIVERSITETSSYKEHUS - HOSPITAL PAGES IN NORWEGIAN

Thor Ueland's publications

Publications by Thor Ueland

226 publications found

Publications in press

  1. Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, Adourian A, Böhm M, van Veldhuisen DJ, Komajda M, Cleland JG, Wikstrand J, McMurray JJ, Aukrust P, on behalf of the CORONA Study Group
    Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
    Eur Heart J (in press)
    PubMed 22513778
  2. Lekva T, Berg JP, Fougner SL, Olstad OK, Ueland T, Bollerslev J
    Gene Expression Profiling Identifies ESRP1 as a Potential Regulator of Epithelial Mesenchymal Transition in Somatotroph Adenomas from a Large Cohort of Patients with Acromegaly
    J Clin Endocrinol Metab (in press)
    PubMed 22585092
  3. Lekva T, Ueland T, Bøyum H, Evang JA, Godang K, Bollerslev J
    TXNIP is highly regulated in bone biopsies from patients with Endogenous Cushing's Syndrome and related to bone turnover
    Eur J Endocrinol (in press)
    PubMed 22450549
  4. Manhenke C, Orn S, von Haehling S, Wollert KC, Ueland T, Aukrust P, Voors AA, Squire I, Zannad F, Anker SD, Dickstein K
    Clustering of 37 circulating biomarkers by exploratory factor analysis in patients following complicated acute myocardial infarction
    Int J Cardiol (in press)
    PubMed 22197217
  5. Orn S, Ueland T, Manhenke C, Sandanger O, Godang K, Yndestad A, Mollnes TE, Dickstein K, Aukrust P
    Increased interleukin-1? levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention
    J Intern Med (in press)
    PubMed 22243053
  6. Solberg OG, Ueland T, Wergeland R, Dahl CP, Aakhus S, Aukrust P, Gullestad L
    High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis
    Scand Cardiovasc J (in press)
    PubMed 22545649
  7. Ueland T, Aukrust P, Aakhus S, Smith C, Endresen K, Birkeland KI, Gullestad L, Johansen OE
    Activin A and cardiovascular disease in type 2 diabetes mellitus
    Diab Vasc Dis Res (in press)
    PubMed 22234949

Publications 2012

  1. Broch K, Eek C, Wergeland R, Ueland T, Skårdal R, Aukrust P, Skulstad H, Gullestad L (2012)
    NT-proBNP predicts myocardial recovery after non-ST-elevation acute coronary syndrome
    Scand Cardiovasc J, 46 (2), 65-71
    PubMed 22191851
  2. Broch K, Ueland T, Nymo SH, Kjekshus J, Hulthe J, Muntendam P, McMurray JJ, Wikstrand J, Cleland JG, Aukrust P, Gullestad L (2012)
    Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology
    Eur J Heart Fail, 14 (3), 268-77
    PubMed 22302661
  3. Damås JK, Bækken M, Ueland T, Manner IW, Os I, Yndestad A, Flo TH, Øktedalen O, Aukrust P (2012)
    Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients
    J Acquir Immune Defic Syndr, 59 (2), e24-5
    PubMed 22245717
  4. Damås JK, Øktedalen O, Ueland T, Landrø L, Barstad J, Müller F, Frøland SS, Flo TH, Aukrust P (2012)
    Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS)
    Clin Exp Immunol, 167 (3), 492-8
    PubMed 22288592
  5. Gjerde B, Bakke PS, Ueland T, Hardie JA, Eagan TM (2012)
    The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway
    Respir Med, 106 (3), 361-6
    PubMed 22129490
  6. Nymo SH, Ueland T, Askevold ET, Flo TH, Kjekshus J, Hulthe J, Wikstrand J, McMurray J, Van Veldhuisen DJ, Gullestad L, Aukrust P, Yndestad A (2012)
    The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*
    J Intern Med, 271 (5), 436-443
    PubMed 22211640
  7. Olarescu NC, Ueland T, Lekva T, Dahl TB, Halvorsen B, Aukrust P, Bollerslev J (2012)
    Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly
    J Clin Endocrinol Metab, 97 (4), 1355-62
    PubMed 22319029
  8. Sikkeland LI, Dahl CP, Ueland T, Andreassen AK, Gude E, Edvardsen T, Holm T, Yndestad A, Gullestad L, Kongerud J, Aukrust P, Oie E (2012)
    Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure
    PLoS One, 7 (5), e36815
    PubMed 22615818
  9. Ueland T, Smedbakken LM, Hallén J, Atar D, Januzzi JL, Halvorsen B, Jensen JK, Aukrust P (2012)
    Soluble CXCL16 and long-term outcome in acute ischemic stroke
    Atherosclerosis, 220 (1), 244-9
    PubMed 22055341
  10. Ueland T, Yndestad A, Dahl CP, Gullestad L, Aukrust P (2012)
    TNF Revisited: Osteoprotegerin and TNF-related Molecules in Heart Failure
    Curr Heart Fail Rep, 9 (2), 92-100
    PubMed 22453763
  11. Yndestad A, Finsen AV, Ueland T, Husberg C, Dahl CP, Øie E, Vinge LE, Sjaastad I, Sandanger Ø, Ranheim T, Dickstein K, Kjekshus J, Damås JK, Fiane AE, Hilfiker-Kleiner D, Lipp M, Gullestad L, Christensen G, Aukrust P (2012)
    The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure
    PLoS One, 7 (3), e33038
    PubMed 22427939

Publications 2011

  1. Andersen GØ, Knudsen EC, Aukrust P, Yndestad A, Oie E, Müller C, Seljeflot I, Ueland T (2011)
    Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
    Heart, 97 (6), 460-5
    PubMed 21270073
  2. Andersen GØ, Ueland T, Knudsen EC, Scholz H, Yndestad A, Sahraoui A, Smith C, Lekva T, Otterdal K, Halvorsen B, Seljeflot I, Aukrust P (2011)
    Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation
    Diabetes, 60 (5), 1544-51
    PubMed 21464440
  3. Andreassen AK, Gude E, Solberg OG, Ueland T (2011)
    [Treatment of idiopathic pulmonary arterial hypertension]
    Tidsskr Nor Laegeforen, 131 (13-14), 1285-8
    PubMed 21725387
  4. Arora S, Ueland T, Wennerblom B, Sigurdadottir V, Eiskjær H, Bøtker HE, Ekmehag B, Jansson K, Mortensen SA, Saunamaki K, Simonsen S, Gude E, Bendz B, Solbu D, Aukrust P, Gullestad L (2011)
    Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial
    Transplantation, 92 (2), 235-43
    PubMed 21677600
  5. Aukrust P, Sandberg WJ, Otterdal K, Vinge LE, Gullestad L, Yndestad A, Halvorsen B, Ueland T (2011)
    Tumor necrosis factor superfamily molecules in acute coronary syndromes
    Ann Med, 43 (2), 90-103
    PubMed 21039303
  6. Berdal JE, Mollnes TE, Wæhre T, Olstad OK, Halvorsen B, Ueland T, Laake JH, Furuseth MT, Maagaard A, Kjekshus H, Aukrust P, Jonassen CM (2011)
    Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza
    J Infect, 63 (4), 308-16
    PubMed 21781987
  7. Brun H, Ueland T, Thaulow E, Damas JK, Yndestad A, Aukrust P, Holmstrøm H (2011)
    No inflammatory response related to pulmonary hemodynamics in children with systemic to pulmonary shunts
    Congenit Heart Dis, 6 (4), 338-46
    PubMed 21450032
  8. Hofsø D, Jenssen T, Bollerslev J, Ueland T, Godang K, Stumvoll M, Sandbu R, Røislien J, Hjelmesæth J (2011)
    Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention
    Eur J Endocrinol, 164 (2), 231-8
    PubMed 21078684
  9. Holm S, Ueland T, Dahl TB, Michelsen AE, Skjelland M, Russell D, Nymo SH, Krohg-Sørensen K, Clausen OP, Atar D, Januzzi JL, Aukrust P, Jensen JK, Halvorsen B (2011)
    Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke
    PLoS One, 6 (12), e28785
    PubMed 22174896
  10. Hope S, Dieset I, Agartz I, Steen NE, Ueland T, Melle I, Aukrust P, Andreassen OA (2011)
    Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia
    J Psychiatr Res, 45 (12), 1608-16
    PubMed 21889167
  11. Jørgensen AP, Fougner KJ, Ueland T, Gudmundsen O, Burman P, Schreiner T, Bollerslev J (2011)
    Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency
    Growth Horm IGF Res, 21 (2), 69-75
    PubMed 21295507
  12. Landrø L, Ueland T, Otterdal K, Frøland SS, Aukrust P (2011)
    Persistently raised plasma levels of platelet-derived inflammatory mediators in HIV-infected patients during highly active anti-retroviral therapy
    J Thromb Haemost, 9 (5), 1075-7
    PubMed 21324059
  13. Munk PS, Breland UM, Aukrust P, Skadberg O, Ueland T, Larsen AI (2011)
    Inflammatory response to percutaneous coronary intervention in stable coronary artery disease
    J Thromb Thrombolysis, 31 (1), 92-8
    PubMed 20373128
  14. Munk PS, Breland UM, Aukrust P, Ueland T, Kvaløy JT, Larsen AI (2011)
    High intensity interval training reduces systemic inflammation in post-PCI patients
    Eur J Cardiovasc Prev Rehabil, 18 (6), 850-7
    PubMed 21450602
  15. Narverud I, Ueland T, Nenseter MS, Retterstøl K, Telle-Hansen VH, Halvorsen B, Ose L, Aukrust P, Holven KB (2011)
    Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor ? system and interleukin-10
    Atherosclerosis, 214 (1), 163-8
    PubMed 21040915
  16. Nenseter MS, Lindvig HW, Ueland T, Langslet G, Ose L, Holven KB, Retterstøl K (2011)
    Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia
    Atherosclerosis, 216 (2), 426-32
    PubMed 21376325
  17. Orre IJ, Reinertsen KV, Aukrust P, Dahl AA, Fosså SD, Ueland T, Murison R (2011)
    Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors
    J Psychosom Res, 71 (3), 136-41
    PubMed 21843747
  18. Persson A, Bollerslev J, Rosen T, Mollerup CL, Franco C, Isaksen GA, Ueland T, Jansson S, Caidahl K, SIPH Study Group (2011)
    Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism
    Clin Endocrinol (Oxf), 74 (2), 174-80
    PubMed 21044114
  19. Smedbakken L, Jensen JK, Hallén J, Atar D, Januzzi JL, Halvorsen B, Aukrust P, Ueland T (2011)
    Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke
    Stroke, 42 (9), 2453-8
    PubMed 21757661
  20. Ueland T, Aukrust P, Broch K, Aakhus S, Skårdal R, Muntendam P, Gullestad L (2011)
    Galectin-3 in heart failure: high levels are associated with all-cause mortality
    Int J Cardiol, 150 (3), 361-4
    PubMed 21641051
  21. Ueland T, Aukrust P, Dahl CP, Husebye T, Solberg OG, Tønnessen T, Aakhus S, Gullestad L (2011)
    Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis
    J Intern Med, 270 (5), 452-60
    PubMed 21623962
  22. Ueland T, Aukrust P, Omdal TR, Damås JK, Endresen K, Ren F, Hysing J (2011)
    Effect of eptifibatide on platelet-mediated inflammation in acute coronary syndromes
    Int J Cardiol, 151 (3), 385-7
    PubMed 21782261
  23. Ueland T, Dahl CP, Gullestad L, Aakhus S, Broch K, Skårdal R, Vermeer C, Aukrust P, Schurgers LJ (2011)
    Circulating levels of non-phosphorylated undercarboxylated matrix Gla protein are associated with disease severity in patients with chronic heart failure
    Clin Sci (Lond), 121 (3), 119-27
    PubMed 21294711
  24. Ueland T, Dahl CP, Kjekshus J, Hulthe J, Böhm M, Mach F, Goudev A, Lindberg M, Wikstrand J, Aukrust P, Gullestad L (2011)
    Osteoprotegerin predicts progression of chronic heart failure: results from CORONA
    Circ Heart Fail, 4 (2), 145-52
    PubMed 21216833
  25. Ueland T, Jørgensen AP, Godang K, Fougner KJ, Aukrust P, Burman P, Bollerslev J (2011)
    Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency
    Clin Endocrinol (Oxf), 74 (1), 60-6
    PubMed 21039720
  26. Ueland T, Lekva T, Otterdal K, Dahl TB, Olarescu NC, Jørgensen AP, Fougner KJ, Brixen K, Aukrust P, Bollerslev J (2011)
    Increased serum and bone matrix levels of transforming growth factor {beta}1 in patients with GH deficiency in response to GH treatment
    Eur J Endocrinol, 165 (3), 393-400
    PubMed 21653735
  27. Øie E, Ueland T, Dahl CP, Bohov P, Berge C, Yndestad A, Gullestad L, Aukrust P, Berge RK (2011)
    Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality
    J Intern Med, 270 (3), 263-72
    PubMed 21466599
  28. Aarones M, Gullestad L, Aakhus S, Ueland T, Skaardal R, Aass H, Wergeland R, Smith HJ, Aukrust P, Kongsgaard E (2011)
    Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapy
    Am Heart J, 161 (6), 1031-7
    PubMed 21641347

Publications 2010

  1. Arora S, Gunther A, Wennerblom B, Ueland T, Andreassen AK, Gude E, Endresen K, Geiran O, Wilhelmsen N, Andersen R, Aukrust P, Gullestad L (2010)
    Systemic markers of inflammation are associated with cardiac allograft vasculopathy and an increased intimal inflammatory component
    Am J Transplant, 10 (6), 1428-36
    PubMed 20486911
  2. Aukrust P, Halvorsen B, Ueland T, Michelsen AE, Skjelland M, Gullestad L, Yndestad A, Otterdal K (2010)
    Activated platelets and atherosclerosis
    Expert Rev Cardiovasc Ther, 8 (9), 1297-307
    PubMed 20828352
  3. Baekken M, Manner I, Ueland T, Frøland SS, Os I, Aukrust P, Oktedalen O, Damås JK (2010)
    Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients
    J Acquir Immune Defic Syndr, 53 (3), 419-20
    PubMed 20190590
  4. Bergestuen DS, Edvardsen T, Aakhus S, Ueland T, Oie E, Vatn M, Aukrust P, Thiis-Evensen E (2010)
    Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis
    Neuroendocrinology, 92 (3), 168-77
    PubMed 20720391
  5. Breland UM, Hollan I, Saatvedt K, Almdahl SM, Damås JK, Yndestad A, Mikkelsen K, Førre OT, Aukrust P, Ueland T (2010)
    Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease
    Rheumatology (Oxford), 49 (6), 1118-27
    PubMed 20231178
  6. Breland UM, Michelsen AE, Skjelland M, Folkersen L, Krohg-Sørensen K, Russell D, Ueland T, Yndestad A, Paulsson-Berne G, Damås JK, Oie E, Hansson GK, Halvorsen B, Aukrust P (2010)
    Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation
    Cardiovasc Res, 86 (2), 265-73
    PubMed 20139115
  7. Caidahl K, Ueland T, Aukrust P (2010)
    Osteoprotegerin: a biomarker with many faces
    Arterioscler Thromb Vasc Biol, 30 (9), 1684-6
    PubMed 20720194
  8. Eagan TM, Aukrust P, Bakke PS, Damås JK, Skorge TD, Hardie JA, Ueland T, Mollnes TE (2010)
    Systemic mannose-binding lectin is not associated with Chronic Obstructive Pulmonary Disease
    Respir Med, 104 (2), 283-90
    PubMed 19836222
  9. Eagan TM, Aukrust P, Ueland T, Hardie JA, Johannessen A, Mollnes TE, Damås JK, Bakke PS, Wagner PD (2010)
    Body composition and plasma levels of inflammatory biomarkers in COPD
    Eur Respir J, 36 (5), 1027-33
    PubMed 20413541
  10. Eagan TM, Damås JK, Ueland T, Voll-Aanerud M, Mollnes TE, Hardie JA, Bakke PS, Aukrust P (2010)
    Neutrophil gelatinase-associated lipocalin: a biomarker in COPD
    Chest, 138 (4), 888-95
    PubMed 20495108
  11. Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damås JK, Aukrust P, Bakke PS (2010)
    Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
    Eur Respir J, 35 (3), 540-8
    PubMed 19643942
  12. Eggum R, Ueland T, Mollnes TE, Videm V, Fiane AE, Aukrust P, Lindberg HL (2010)
    Perfusion temperature, thyroid hormones and inflammation during pediatric cardiac surgery
    Interact Cardiovasc Thorac Surg, 10 (1), 76-80
    PubMed 19822605
  13. Friis CM, Froslie KF, Roislien J, Voldner N, Godang K, Ueland T, Bollerslev J, Veierod MB, Henriksen T (2010)
    The interleukins IL-6 and IL-1Ra: a mediating role in the associations between BMI and birth weight?
    J. Dev. Orig. Health Dis., 1 (5), 310-318
  14. Gregersen S, Aaløkken TM, Mynarek G, Fevang B, Holm AM, Ueland T, Aukrust P, Kongerud J, Johansen B, Frøland SS (2010)
    Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors
    Ann Allergy Asthma Immunol, 104 (6), 503-10
    PubMed 20568383
  15. Halvorsen B, Heggen E, Ueland T, Smith C, Sandberg WJ, Damås JK, Otterdal K, Tonstad S, Aukrust P (2010)
    Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
    Eur J Endocrinol, 162 (2), 267-73
    PubMed 19926782
  16. Hope S, Melle I, Aukrust P, Agartz I, Lorentzen S, Steen NE, Djurovic S, Ueland T, Andreassen OA (2010)
    Osteoprotegerin levels in patients with severe mental disorders
    J Psychiatry Neurosci, 35 (5), 304-10
    PubMed 20569643
  17. Jensen JK, Ueland T, Atar D, Gullestad L, Mickley H, Aukrust P, Januzzi JL (2010)
    Osteoprotegerin concentrations and prognosis in acute ischaemic stroke
    J Intern Med, 267 (4), 410-7
    PubMed 19895657
  18. Lekva T, Bollerslev J, Kristo C, Olstad OK, Ueland T, Jemtland R (2010)
    The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing's syndrome and may play a role in glucocorticoid-induced osteoporosis
    J Clin Endocrinol Metab, 95 (1), 246-55
    PubMed 19875485
  19. Lien G, Ueland T, Godang K, Selvaag AM, Førre OT, Flatø B (2010)
    Serum levels of osteoprotegerin and receptor activator of nuclear factor -?B ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study
    Pediatr Rheumatol Online J, 8, 30
    PubMed 21134287
  20. Pedersen ER, Ueland T, Seifert R, Aukrust P, Schartum-Hansen H, Ebbing M, Bleie Ø, Igland J, Svingen G, Nordrehaug JE, Nygård O (2010)
    Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris
    Atherosclerosis, 212 (2), 644-9
    PubMed 20621297
  21. Rødland EK, Ueland T, Pedersen TM, Halvorsen B, Muller F, Aukrust P, Frøland SS (2010)
    Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis
    Infect Immun, 78 (3), 1269-75
    PubMed 20008537
  22. Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust P, Bollerslev J (2010)
    Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly
    J Clin Endocrinol Metab, 95 (1), 361-8
    PubMed 19880791
  23. Ueland T, Gullestad L, Dahl CP, Aukrust P, Aakhus S, Solberg OG, Vermeer C, Schurgers LJ (2010)
    Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis
    J Intern Med, 268 (5), 483-92
    PubMed 20804515
  24. Wethal T, Haugnes HS, Kjekshus J, Småstuen MC, Ueland T, Aukrust P, Fosså SD (2010)
    C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?
    Eur J Cancer, 46 (18), 3425-33
    PubMed 20832295
  25. Øie E, Ahmed MS, Ueland T, Sikkeland LI, Dahl CP, Hagelin EM, von Lueder T, Edvardsen T, Andreassen AK, Gullestad L, Aukrust P, Yndestad A, Vinge LE, Attramadal H (2010)
    Adrenomedullin is increased in alveolar macrophages and released from the lungs into the circulation in severe heart failure
    Basic Res Cardiol, 105 (1), 89-98
    PubMed 19823891

Publications 2009

  1. Arora S, Aukrust P, Ueland T, Broch K, Simonsen S, Gude E, Fiane AE, Geiran O, Wergeland R, Andreassen AK, Gullestad L (2009)
    Elevated serum uric acid levels following heart transplantation predict all-cause and cardiac mortality
    Eur J Heart Fail, 11 (10), 1005-13
    PubMed 19737803
  2. Aukrust P, Ueland T, Gullestad L, Yndestad A (2009)
    Testosterone: a novel therapeutic approach in chronic heart failure?
    J Am Coll Cardiol, 54 (10), 928-9
    PubMed 19712803
  3. Bollerslev J, Rosen T, Mollerup CL, Nordenström J, Baranowski M, Franco C, Pernow Y, Isaksen GA, Godang K, Ueland T, Jansson S, SIPH Study Group (2009)
    Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism
    J Clin Endocrinol Metab, 94 (7), 2255-61
    PubMed 19351725
  4. Brun H, Holmstrøm H, Thaulow E, Damås JK, Yndestad A, Aukrust P, Ueland T (2009)
    Patients with pulmonary hypertension related to congenital systemic-to-pulmonary shunts are characterized by inflammation involving endothelial cell activation and platelet-mediated inflammation
    Congenit Heart Dis, 4 (3), 153-9
    PubMed 19489942
  5. Dahl CP, Husberg C, Gullestad L, Waehre A, Damås JK, Vinge LE, Finsen AV, Ueland T, Florholmen G, Aakhus S, Halvorsen B, Aukrust P, Oie E, Yndestad A, Christensen G (2009)
    Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling
    Circ Heart Fail, 2 (6), 624-32
    PubMed 19919988
  6. Damås JK, Davì G, Jensenius M, Santilli F, Otterdal K, Ueland T, Flo TH, Lien E, Espevik T, Frøland SS, Vitale G, Raoult D, Aukrust P (2009)
    Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever
    J Infect, 58 (1), 68-75
    PubMed 19091423
  7. Dolgos S, Hartmann A, Bønsnes S, Isaksen GA, Godang K, Ueland T, Pfeffer P, Bollerslev J (2009)
    Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation
    Scand J Clin Lab Invest, 69 (2), 161-7
    PubMed 18972258
  8. Fevang B, Yndestad A, Damås JK, Bjerkeli V, Ueland T, Holm AM, Beiske K, Aukrust P, Frøland SS (2009)
    Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation
    Clin Immunol, 130 (2), 151-61
    PubMed 18938112
  9. Hofsø D, Ueland T, Hager H, Jenssen T, Bollerslev J, Godang K, Aukrust P, Røislien J, Hjelmesaeth J (2009)
    Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose
    Eur J Endocrinol, 161 (3), 451-8
    PubMed 19542241
  10. Hope S, Melle I, Aukrust P, Steen NE, Birkenaes AB, Lorentzen S, Agartz I, Ueland T, Andreassen OA (2009)
    Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor
    Bipolar Disord, 11 (7), 726-34
    PubMed 19839997
  11. Jansson AM, Aukrust P, Ueland T, Smith C, Omland T, Hartford M, Caidahl K (2009)
    Soluble CXCL16 predicts long-term mortality in acute coronary syndromes
    Circulation, 119 (25), 3181-8
    PubMed 19528340
  12. Johansen OE, Birkeland KI, Jørgensen AP, Orvik E, Sørgård B, Torjussen BR, Ueland T, Aukrust P, Gullestad L (2009)
    Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial
    J Diabetes, 1 (3), 182-7
    PubMed 20923537
  13. Landrø L, Damås JK, Halvorsen B, Fevang B, Ueland T, Otterdal K, Heggelund L, Frøland SS, Aukrust P (2009)
    CXCL16 in HIV infection - a link between inflammation and viral replication
    Eur J Clin Invest, 39 (11), 1017-24
    PubMed 19674076
  14. Nenseter MS, Ueland T, Retterstøl K, Strøm E, Mørkrid L, Landaas S, Ose L, Aukrust P, Holven KB (2009)
    Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of treatment with B-vitamins
    Stroke, 40 (1), 241-7
    PubMed 19008470
  15. Orn S, Breland UM, Mollnes TE, Manhenke C, Dickstein K, Aukrust P, Ueland T (2009)
    The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction
    Am J Cardiol, 104 (9), 1179-83
    PubMed 19840558
  16. Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, Fosså SD (2009)
    Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue
    Brain Behav Immun, 23 (6), 868-74
    PubMed 19362138
  17. Semb AG, Ueland T, Aukrust P, Wareham NJ, Luben R, Gullestad L, Kastelein JJ, Khaw KT, Boekholdt SM (2009)
    Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003
    Arterioscler Thromb Vasc Biol, 29 (6), 975-80
    PubMed 19325145
  18. Ueland T, Otterdal K, Lekva T, Halvorsen B, Gabrielsen A, Sandberg WJ, Paulsson-Berne G, Pedersen TM, Folkersen L, Gullestad L, Oie E, Hansson GK, Aukrust P (2009)
    Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis
    Arterioscler Thromb Vasc Biol, 29 (8), 1228-34
    PubMed 19498175
  19. Ueland T, Wilson SG, Amirul Islam FM, Mullin B, Devine A, Bollerslev J, Zhu K, Prince RL (2009)
    A cohort study of the effects of serum osteoprotegerin and osteoprotegerin gene polymorphisms on cardiovascular mortality in elderly women
    Clin Endocrinol (Oxf), 71 (6), 828-33
    PubMed 19508593
  20. Yndestad A, Landrø L, Ueland T, Dahl CP, Flo TH, Vinge LE, Espevik T, Frøland SS, Husberg C, Christensen G, Dickstein K, Kjekshus J, Øie E, Gullestad L, Aukrust P (2009)
    Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
    Eur Heart J, 30 (10), 1229-36
    PubMed 19329498
  21. Yndestad A, Larsen KO, Oie E, Ueland T, Smith C, Halvorsen B, Sjaastad I, Skjønsberg OH, Pedersen TM, Anfinsen OG, Damås JK, Christensen G, Aukrust P, Andreassen AK (2009)
    Elevated levels of activin A in clinical and experimental pulmonary hypertension
    J Appl Physiol, 106 (4), 1356-64
    PubMed 19196915
  22. Ørn S, Manhenke C, Ueland T, Damås JK, Mollnes TE, Edvardsen T, Aukrust P, Dickstein K (2009)
    C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction
    Eur Heart J, 30 (10), 1180-6
    PubMed 19299430

Publications 2008

  1. Aukrust P, Halvorsen B, Yndestad A, Ueland T, Øie E, Otterdal K, Gullestad L, Damås JK (2008)
    Chemokines and cardiovascular risk
    Arterioscler Thromb Vasc Biol, 28 (11), 1909-19
    PubMed 18669888
  2. Aukrust P, Otterdal K, Yndestad A, Sandberg WJ, Smith C, Ueland T, Øie E, Damås JK, Gullestad L, Halvorsen B (2008)
    The complex role of T-cell-based immunity in atherosclerosis
    Curr Atheroscler Rep, 10 (3), 236-43
    PubMed 18489852
  3. Dolgos S, Hartmann A, Bønsnes S, Ueland T, Isaksen GA, Godang K, Pfeffer P, Bollerslev J (2008)
    Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation
    Clin Transplant, 22 (4), 462-8
    PubMed 18318737
  4. Eggum R, Ueland T, Mollnes TE, Videm V, Aukrust P, Fiane AE, Lindberg HL (2008)
    Effect of perfusion temperature on the inflammatory response during pediatric cardiac surgery
    Ann Thorac Surg, 85 (2), 611-7
    PubMed 18222275
  5. Gravning J, Ueland T, Mørkrid L, Endresen K, Aaberge L, Kjekshus J (2008)
    Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris
    Scand Cardiovasc J, 42 (3), 214-21
    PubMed 18569954
  6. Handberg A, Skjelland M, Michelsen AE, Sagen EL, Krohg-Sørensen K, Russell D, Dahl A, Ueland T, Oie E, Aukrust P, Halvorsen B (2008)
    Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability
    Stroke, 39 (11), 3092-5
    PubMed 18723424
  7. Kristo C, Ueland T, Godang K, Aukrust P, Bollerslev J (2008)
    Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome
    J Endocrinol Invest, 31 (5), 400-5
    PubMed 18560257
  8. Landrø L, Damås JK, Flo TH, Heggelund L, Ueland T, Tjønnfjord GE, Espevik T, Aukrust P, Frøland SS (2008)
    Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy
    Clin Exp Immunol, 152 (1), 57-63
    PubMed 18241231
  9. Omland T, Ueland T, Jansson AM, Persson A, Karlsson T, Smith C, Herlitz J, Aukrust P, Hartford M, Caidahl K (2008)
    Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes
    J Am Coll Cardiol, 51 (6), 627-33
    PubMed 18261681
  10. Otterdal K, Andreassen AK, Yndestad A, Oie E, Sandberg WJ, Dahl CP, Pedersen TM, Ueland T, Gullestad L, Brosstad FR, Aukrust P, Damås JK (2008)
    Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation
    Am J Respir Crit Care Med, 177 (2), 202-7
    PubMed 17962639
  11. Risnes I, Wagner K, Ueland T, Mollnes T, Aukrust P, Svennevig J (2008)
    Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment
    Perfusion, 23 (3), 173-8
    PubMed 19029268
  12. Ueland T, Dalsoren T, Voldner N, Godang K, Henriksen T, Bollerslev J (2008)
    Retinol-binding protein-4 is not strongly associated with insulin sensitivity in normal pregnancies
    Eur J Endocrinol, 159 (1), 49-54
    PubMed 18426814

Publications 2007

  1. Abedin M, Omland T, Ueland T, Khera A, Aukrust P, Murphy SA, Jain T, Gruntmanis U, McGuire DK, de Lemos JA (2007)
    Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study)
    Am J Cardiol, 99 (4), 513-8
    PubMed 17293196
  2. Arora S, Gullestad L, Wergeland R, Simonsen S, Holm T, Hognestad A, Ueland T, Geiran O, Andreassen A (2007)
    Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation
    Transplantation, 83 (10), 1308-15
    PubMed 17519779
  3. Aukrust P, Yndestad A, Damås JK, Ueland T, Øie E, Gullestad L (2007)
    Potential mechanisms of benefit with thalidomide in chronic heart failure
    Am J Cardiovasc Drugs, 7 (2), 127-34
    PubMed 17503883
  4. Aukrust P, Yndestad A, Smith C, Ueland T, Gullestad L, Damås JK (2007)
    Chemokines in cardiovascular risk prediction
    Thromb Haemost, 97 (5), 748-54
    PubMed 17479185
  5. Bollerslev J, Jansson S, Mollerup CL, Nordenström J, Lundgren E, Tørring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T (2007)
    Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial
    J Clin Endocrinol Metab, 92 (5), 1687-92
    PubMed 17284629
  6. Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Frøland SS, Krohg-Sørensen K, Russell D, Aukrust P, Halvorsen B (2007)
    Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization
    Circulation, 115 (8), 972-80
    PubMed 17283255
  7. Dyrøy E, Røst TH, Pettersen RJ, Halvorsen B, Gudbrandsen OA, Ueland T, Muna Z, Müller F, Nordrehaug JE, Aukrust P, Berge RK (2007)
    Tetradecylselenoacetic acid, a PPAR ligand with antioxidant, antiinflammatory, and hypolipidemic properties
    Arterioscler Thromb Vasc Biol, 27 (3), 628-34
    PubMed 17185614
  8. Gullestad L, Oie E, Ueland T, Yndestad A, Aukrust P (2007)
    The role of statins in heart failure
    Fundam Clin Pharmacol, 21 Suppl 2, 35-40
    PubMed 18001320
  9. Halvorsen B, Lund Sagen E, Ueland T, Aukrust P, Tonstad S (2007)
    Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease
    Scand J Clin Lab Invest, 67 (6), 604-11
    PubMed 17852807
  10. Johansen OE, Birkeland KI, Orvik E, Flesland Ø, Wergeland R, Ueland T, Smith C, Endresen K, Aukrust P, Gullestad L (2007)
    Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects
    Scand J Clin Lab Invest, 67 (3), 306-16
    PubMed 17454845
  11. Omland T, Drazner MH, Ueland T, Abedin M, Murphy SA, Aukrust P, de Lemos JA (2007)
    Plasma osteoprotegerin levels in the general population: relation to indices of left ventricular structure and function
    Hypertension, 49 (6), 1392-8
    PubMed 17470718
  12. Ueland T, Bollerslev J, Wilson SG, Dick IM, Islam FM, Mullin BH, Devine A, Prince RL (2007)
    No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women
    Bone, 40 (1), 175-81
    PubMed 16949901
  13. Wethal T, Kjekshus J, Røislien J, Ueland T, Andreassen AK, Wergeland R, Aukrust P, Fosså SD (2007)
    Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer
    J Cancer Surviv, 1 (1), 8-16
    PubMed 18648940
  14. Yndestad A, Damås JK, Øie E, Ueland T, Gullestad L, Aukrust P (2007)
    Role of inflammation in the progression of heart failure
    Curr Cardiol Rep, 9 (3), 236-41
    PubMed 17470337

Publications 2006

  1. Andreassen AK, Wergeland R, Simonsen S, Geiran O, Guevara C, Ueland T (2006)
    N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension
    Am J Cardiol, 98 (4), 525-9
    PubMed 16893710
  2. Aukrust P, Yndestad A, Ueland T, Damås JK, Frøland SS, Gullestad L (2006)
    The role of intravenous immunoglobulin in the treatment of chronic heart failure
    Int J Cardiol, 112 (1), 40-5
    PubMed 16893578
  3. Aukrust P, Yndestad A, Ueland T, Damås JK, Gullestad L (2006)
    Anti-inflammatory trials in chronic heart failure
    Heart Fail Monit, 5 (1), 2-9
    PubMed 16547529
  4. Bollerslev J, Ueland T, Jørgensen AP, Fougner KJ, Wergeland R, Schreiner T, Burman P (2006)
    Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency
    Eur J Endocrinol, 154 (4), 537-43
    PubMed 16556716
  5. Damås JK, Jensenius M, Ueland T, Otterdal K, Yndestad A, Frøland SS, Rolain JM, Myrvang B, Raoult D, Aukrust P (2006)
    Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets
    J Immunol, 177 (4), 2699-706
    PubMed 16888032
  6. Hjelmesaeth J, Flyvbjerg A, Jenssen T, Frystyk J, Ueland T, Hagen M, Hartmann A (2006)
    Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: impact of immunosuppressive and antihypertensive drug therapy
    Clin J Am Soc Nephrol, 1 (3), 575-82
    PubMed 17699261
  7. Hjelmesaeth J, Ueland T, Flyvbjerg A, Bollerslev J, Leivestad T, Jenssen T, Hansen TK, Thiel S, Sagedal S, Røislien J, Hartmann A (2006)
    Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients
    J Am Soc Nephrol, 17 (6), 1746-54
    PubMed 16687626
  8. Holm T, Ueland T, Halvorsen B, Hognestad A, Holm AG, Wergeland R, Gullestad L, Aukrust P, Kjekshus J (2006)
    A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery disease
    J Am Coll Cardiol, 47 (5), 1085-6
    PubMed 16516099
  9. Holven KB, Damås JK, Yndestad A, Waehre T, Ueland T, Halvorsen B, Heggelund L, Sandberg WJ, Semb AG, Frøland SS, Ose L, Nenseter MS, Aukrust P (2006)
    Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES
    Arterioscler Thromb Vasc Biol, 26 (1), 200-5
    PubMed 16254204
  10. Johansen OE, Birkeland KI, Brustad E, Aaser E, Lindahl AK, Midha R, Ueland T, Aukrust P, Gullestad L (2006)
    Undiagnosed dysglycaemia and inflammation in cardiovascular disease
    Eur J Clin Invest, 36 (8), 544-51
    PubMed 16893376
  11. Kristo C, Jemtland R, Ueland T, Godang K, Bollerslev J (2006)
    Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study
    Eur J Endocrinol, 154 (1), 109-18
    PubMed 16381999
  12. Risnes I, Wagner K, Nome T, Sundet K, Jensen J, Hynås IA, Ueland T, Pedersen T, Svennevig JL (2006)
    Cerebral outcome in adult patients treated with extracorporeal membrane oxygenation
    Ann Thorac Surg, 81 (4), 1401-6
    PubMed 16564280
  13. Sandberg WJ, Yndestad A, Øie E, Smith C, Ueland T, Ovchinnikova O, Robertson AK, Müller F, Semb AG, Scholz H, Andreassen AK, Gullestad L, Damås JK, Frøland SS, Hansson GK, Halvorsen B, Aukrust P (2006)
    Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization
    Arterioscler Thromb Vasc Biol, 26 (4), 857-63
    PubMed 16424351
  14. Ueland T, Aukrust P, Damas JK, Gullestad L, Yndestad A (2006)
    The tumor necrosis factor superfamily in heart failure
    Future Cardiol, 2 (1), 101-11
    PubMed 19804137
  15. Ueland T, Espevik T, Kjekshus J, Gullestad L, Omland T, Squire IB, Frøland SS, Mollnes TE, Dickstein K, Aukrust P (2006)
    Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction
    J Card Fail, 12 (8), 659-63
    PubMed 17045187
  16. Ueland T, Fougner SL, Godang K, Schreiner T, Bollerslev J (2006)
    Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients
    Eur J Endocrinol, 155 (5), 709-15
    PubMed 17062887
  17. Ueland T, Gullestad L, Simonsen S, Endresen K, Scott H, Frøland SS, Geiran O, Fiane AE, Aukrust P (2006)
    Decreased endomyocardial RANKL expression in transplant coronary artery disease
    Transplantation, 81 (10), 1467-70
    PubMed 16732187
  18. Ueland T, Vissers MN, Wiegman A, Rodenburg J, Hutten B, Gullestad L, Ose L, Rifai N, Ridker PM, Kastelein JJ, Aukrust P, Semb AG (2006)
    Increased inflammatory markers in children with familial hypercholesterolaemia
    Eur J Clin Invest, 36 (3), 147-52
    PubMed 16506958
  19. Waehre T, Damås JK, Pedersen TM, Gullestad L, Yndestad A, Andreassen AK, Frøland SS, Semb AG, Hansteen V, Gjertsen E, Ueland T, Brosstad F, Solum NO, Aukrust P (2006)
    Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study
    J Thromb Haemost, 4 (10), 2140-7
    PubMed 16856976
  20. Yndestad A, Damås JK, Oie E, Ueland T, Gullestad L, Aukrust P (2006)
    Systemic inflammation in heart failure--the whys and wherefores
    Heart Fail Rev, 11 (1), 83-92
    PubMed 16819581
  21. Yndestad A, Vinge LE, Bjørnerheim R, Ueland T, Wang JE, Frøland SS, Attramadal H, Aukrust P, Oie E (2006)
    Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats
    Eur J Heart Fail, 8 (8), 790-6
    PubMed 16549389

Publications 2005

  1. Aukrust P, Gullestad L, Ueland T, Damås JK, Yndestad A (2005)
    Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications
    Ann Med, 37 (2), 74-85
    PubMed 16026115
  2. Aukrust P, Luna L, Ueland T, Johansen RF, Müller F, Frøland SS, Seeberg EC, Bjørås M (2005)
    Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients
    Blood, 105 (12), 4730-5
    PubMed 15705786
  3. Aukrust P, Yndestad A, Smith C, Sandberg WJ, Ueland T, Waehre T, Halvorsen B, Gullestad L, Damås JK (2005)
    Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation
    Expert Opin Pharmacother, 6 (13), 2169-80
    PubMed 16218879
  4. Bollerslev J, Wilson SG, Dick IM, Islam FM, Ueland T, Palmer L, Devine A, Prince RL (2005)
    LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women
    Bone, 36 (4), 599-606
    PubMed 15777745
  5. Dyrøy E, Yndestad A, Ueland T, Halvorsen B, Damås JK, Aukrust P, Berge RK (2005)
    Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways
    Arterioscler Thromb Vasc Biol, 25 (7), 1364-9
    PubMed 15920037
  6. Fevang B, Mollnes TE, Holm AM, Ueland T, Heggelund L, Damås JK, Aukrust P, Frøland SS (2005)
    Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis
    Clin Exp Immunol, 142 (3), 576-84
    PubMed 16297171
  7. Fiane AE, Ueland T, Simonsen S, Scott H, Endresen K, Gullestad L, Geiran OR, Haraldsen G, Heggelund L, Andreassen AK, Wergeland R, Frøland S, Aukrust P, Mollnes TE (2005)
    Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation
    Eur Heart J, 26 (16), 1660-5
    PubMed 15821010
  8. Gullestad L, Kjekshus J, Damås JK, Ueland T, Yndestad A, Aukrust P (2005)
    Agents targeting inflammation in heart failure
    Expert Opin Investig Drugs, 14 (5), 557-66
    PubMed 15926863
  9. Gullestad L, Ueland T, Fjeld JG, Holt E, Gundersen T, Breivik K, Følling M, Hodt A, Skårdal R, Kjekshus J, Andreassen A, Kjekshus E, Wergeland R, Yndestad A, Frøland SS, Semb AG, Aukrust P (2005)
    Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study
    Circulation, 112 (22), 3408-14
    PubMed 16301340
  10. Gurantz D, Yndestad A, Halvorsen B, Lunde OV, Omens JH, Ueland T, Aukrust P, Moore CD, Kjekshus J, Greenberg BH (2005)
    Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling
    Cardiovasc Res, 67 (1), 106-15
    PubMed 15949474
  11. Henriksen K, Gram J, Høegh-Andersen P, Jemtland R, Ueland T, Dziegiel MH, Schaller S, Bollerslev J, Karsdal MA (2005)
    Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo
    Am J Pathol, 167 (5), 1341-8
    PubMed 16251418
  12. Hestad KA, Tønseth S, Støen CD, Ueland T, Aukrust P (2005)
    Inflammation and depression: further studies are needed
    J ECT, 21 (1), 52
    PubMed 15791184
  13. Ueland T (2005)
    GH/IGF-I and bone resorption in vivo and in vitro
    Eur J Endocrinol, 152 (3), 327-32
    PubMed 15757846
  14. Ueland T, Aukrust P, Yndestad A, Otterdal K, Frøland SS, Dickstein K, Kjekshus J, Gullestad L, Damås JK (2005)
    Soluble CD40 ligand in acute and chronic heart failure
    Eur Heart J, 26 (11), 1101-7
    PubMed 15716285
  15. Ueland T, Bollerslev J (2005)
    Bone metabolism and growth hormone deficiency. Experimental and clinical aspects
    Front Horm Res, 33, 146-60
    PubMed 16166760
  16. Ueland T, Kjekshus J, Frøland SS, Omland T, Squire IB, Gullestad L, Dickstein K, Aukrust P (2005)
    Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients
    J Am Coll Cardiol, 46 (11), 2018-21
    PubMed 16325035
  17. Ueland T, Yndestad A, Øie E, Florholmen G, Halvorsen B, Frøland SS, Simonsen S, Christensen G, Gullestad L, Aukrust P (2005)
    Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure
    Circulation, 111 (19), 2461-8
    PubMed 15883214

Publications 2004

  1. Burski K, Ueland T, Maciejewski R (2004)
    Serum amylase activity disorders in the course of experimental diabetes in rabbits
    Vet. Med., 49 (6), 197-200
  2. Fredriksen J, Ueland T, Dyrøy E, Halvorsen B, Melby K, Melbye L, Skalhegg BS, Bohov P, Skorve J, Berge RK, Aukrust P, Frøland SS (2004)
    Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy
    Eur J Clin Invest, 34 (10), 709-15
    PubMed 15473896
  3. Heggelund L, Flo T, Berg K, Lien E, Mollnes TE, Ueland T, Aukrust P, Espevik T, Frøland SS (2004)
    Soluble toll-like receptor 2 in HIV infection: association with disease progression
    AIDS, 18 (18), 2437-9
    PubMed 15622324
  4. Heggelund L, Müller F, Lien E, Yndestad A, Ueland T, Kristiansen KI, Espevik T, Aukrust P, Frøland SS (2004)
    Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication
    Clin Infect Dis, 39 (2), 264-9
    PubMed 15307037
  5. Smith C, Yndestad A, Halvorsen B, Ueland T, Waehre T, Otterdal K, Scholz H, Endresen K, Gullestad L, Frøland SS, Damås JK, Aukrust P (2004)
    Potential anti-inflammatory role of activin A in acute coronary syndromes
    J Am Coll Cardiol, 44 (2), 369-75
    PubMed 15261933
  6. Ueland T (2004)
    Bone metabolism in relation to alterations in systemic growth hormone
    Growth Horm IGF Res, 14 (6), 404-17
    PubMed 15519248
  7. Ueland T, Jemtland R, Godang K, Kjekshus J, Hognestad A, Omland T, Squire IB, Gullestad L, Bollerslev J, Dickstein K, Aukrust P (2004)
    Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction
    J Am Coll Cardiol, 44 (10), 1970-6
    PubMed 15542278
  8. Ueland T, Rund BR (2004)
    A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis
    Acta Psychiatr Scand, 109 (1), 70-4
    PubMed 14674961
  9. Yndestad A, Ueland T, Øie E, Florholmen G, Halvorsen B, Attramadal H, Simonsen S, Frøland SS, Gullestad L, Christensen G, Damås JK, Aukrust P (2004)
    Elevated levels of activin A in heart failure: potential role in myocardial remodeling
    Circulation, 109 (11), 1379-85
    PubMed 14993131

Publications 2003

  1. Aukrust P, Müller F, Svardal AM, Ueland T, Berge RK, Frøland SS (2003)
    Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants
    J Infect Dis, 188 (2), 232-8
    PubMed 12854078
  2. Aukrust P, Wergedahl H, Müller F, Ueland T, Dyrøy E, Damås JK, Frøland SS, Berge RK (2003)
    Immunomodulating effects of 3-thia fatty acids in activated peripheral blood mononuclear cells
    Eur J Clin Invest, 33 (5), 426-33
    PubMed 12713457
  3. Bollerslev J, Ueland T, Odgren PR (2003)
    Serum levels of TGF-beta and fibronectin in autosomal dominant osteopetrosis in relation to underlying mutations and well-described murine counterparts
    Crit Rev Eukaryot Gene Expr, 13 (2-4), 163-71
    PubMed 14696964
  4. Heggelund L, Mollnes TE, Ueland T, Christophersen B, Aukrust P, Frøland SS (2003)
    Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy
    J Acquir Immune Defic Syndr, 32 (4), 354-61
    PubMed 12640191
  5. Hestad KA, Tønseth S, Støen CD, Ueland T, Aukrust P (2003)
    Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy
    J ECT, 19 (4), 183-8
    PubMed 14657769
  6. Holm T, Damås JK, Holven K, Nordøy I, Brosstad FR, Ueland T, Währe T, Kjekshus J, Frøland SS, Eiken HG, Solum NO, Gullestad L, Nenseter M, Aukrust P (2003)
    CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells
    J Thromb Haemost, 1 (2), 257-62
    PubMed 12871498
  7. Jensenius M, Ueland T, Fournier PE, Brosstad F, Stylianou E, Vene S, Myrvang B, Raoult D, Aukrust P (2003)
    Systemic inflammatory responses in African tick-bite fever
    J Infect Dis, 187 (8), 1332-6
    PubMed 12696016
  8. Risnes I, Ueland T, Aukrust P, Lundblad R, Baksaas ST, Mollnes TE, Svennevig JL (2003)
    Complement activation and cytokine and chemokines release during mediastinitis
    Ann Thorac Surg, 75 (3), 981-5
    PubMed 12645727
  9. Risnes I, Ueland T, Lundblad R, Mollnes TE, Baksaas ST, Aukrust P, Svennevig JL (2003)
    Changes in the cytokine network and complement parameters during open heart surgery
    Interact Cardiovasc Thorac Surg, 2 (1), 19-24
    PubMed 17669979
  10. Semb AG, van Wissen S, Ueland T, Smilde T, Waehre T, Tripp MD, Frøland SS, Kastelein JJ, Gullestad L, Pedersen TR, Aukrust P, Stalenhoef AF (2003)
    Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy
    J Am Coll Cardiol, 41 (2), 275-9
    PubMed 12535822
  11. Ueland T, Brixen K, Mosekilde L, Mosekilde L, Flyvbjerg A, Bollerslev J (2003)
    Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study
    J Clin Endocrinol Metab, 88 (3), 1014-8
    PubMed 12629078
  12. Ueland T, Kristo C, Godang K, Aukrust P, Bollerslev J (2003)
    Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study
    J Clin Endocrinol Metab, 88 (4), 1492-6
    PubMed 12679428
  13. Ueland T, Odgren PR, Yndestad A, Godang K, Schreiner T, Marks SC, Bollerslev J (2003)
    Growth hormone substitution increases gene expression of members of the IGF family in cortical bone from women with adult onset growth hormone deficiency--relationship with bone turn-over
    Bone, 33 (4), 638-45
    PubMed 14555269
  14. Ueland T, Sikkeland LI, Yndestad A, Eiken HG, Holm T, Guevara C, Haug T, Endresen K, Frøland SS, Gullestad L, Andreassen AK, Geiran O, Simonsen S, Aukrust P (2003)
    Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease
    Am J Cardiol, 92 (6), 715-7
    PubMed 12972116

Publications 2002

  1. Damås JK, Waehre T, Yndestad A, Ueland T, Müller F, Eiken HG, Holm AM, Halvorsen B, Frøland SS, Gullestad L, Aukrust P (2002)
    Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects
    Circulation, 106 (1), 36-42
    PubMed 12093767
  2. Gullestad L, Semb AG, Holt E, Skårdal R, Ueland T, Yndestad A, Frøland SS, Aukrust P (2002)
    Effect of thalidomide in patients with chronic heart failure
    Am Heart J, 144 (5), 847-50
    PubMed 12422154
  3. Holm T, Aukrust P, Aagaard E, Ueland T, Haugstad TS, Kjekshus J, Simonsen S, Frøland SS, Gullestad L, Andreassen AK (2002)
    Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension
    Transplantation, 74 (10), 1395-400
    PubMed 12451238
  4. Kristo C, Godang K, Ueland T, Lien E, Aukrust P, Froland SS, Bollerslev J (2002)
    Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome
    Eur J Endocrinol, 146 (3), 389-95
    PubMed 11888846
  5. Mellembakken JR, Aukrust P, Olafsen MK, Ueland T, Hestdal K, Videm V (2002)
    Activation of leukocytes during the uteroplacental passage in preeclampsia
    Hypertension, 39 (1), 155-60
    PubMed 11799095
  6. Ueland T, Bollerslev J, Flyvbjerg A, Hansen TB, Vahl N, Mosekilde L (2002)
    Effects of 12 months of GH treatment on cortical and trabecular bone content of IGFs and OPG in adults with acquired GH deficiency: a double-blind, randomized, placebo-controlled study
    J Clin Endocrinol Metab, 87 (6), 2760-3
    PubMed 12050246
  7. Ueland T, Bollerslev J, Mosekilde L (2002)
    [Osteoclast function is regulated by neighbouring osteoblasts. Osteoprotegerin, RAND and RANK ligand constitute a unique regulatory system for bone resorption with important pathophysiological and therapeutic aspects]
    Ugeskr Laeger, 164 (27), 3526-30
    PubMed 12116680
  8. Ueland T, Ebbesen EN, Thomsen JS, Mosekilde L, Brixen K, Flyvbjerg A, Bollerslev J (2002)
    Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly
    Eur J Clin Invest, 32 (2), 122-8
    PubMed 11895459

Publications 2001

  1. Aukrust P, Berge RK, Ueland T, Aaser E, Damås JK, Wikeby L, Brunsvig A, Müller F, Forfang K, Frøland SS, Gullestad L (2001)
    Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes
    J Am Coll Cardiol, 37 (2), 485-91
    PubMed 11216967
  2. Aukrust P, Gullestad L, Lappegård KT, Ueland T, Aass H, Wikeby L, Simonsen S, Frøland SS, Mollnes TE (2001)
    Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment
    Circulation, 104 (13), 1494-500
    PubMed 11571242
  3. Aukrust P, Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Froland SS (2001)
    Increase in anti-inflammatory cytokine levels in chronic heart failure: A measure of treatment success or failure? Response
    Circulation, 104 (18), E97-E98
  4. Damås JK, Aukrust P, Ueland T, Odegaard A, Eiken HG, Gullestad L, Sejersted OM, Christensen G (2001)
    Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes
    Basic Res Cardiol, 96 (4), 345-52
    PubMed 11518190
  5. Damås JK, Gullestad L, Aass H, Simonsen S, Fjeld JG, Wikeby L, Ueland T, Eiken HG, Frøland SS, Aukrust P (2001)
    Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin
    J Am Coll Cardiol, 38 (1), 187-93
    PubMed 11451272
  6. Gullestad L, Ueland T, Brunsvig A, Kjekshus J, Simonsen S, Frøland SS, Aukrust P (2001)
    Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF)
    Am Heart J, 141 (3), 418-21
    PubMed 11231439
  7. Gullestad L, Aass H, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Wikeby L, Nitter-Hauge S, Fjeld JG, Lien E, Ueland T, Frøland SS, Aukrust P (2001)
    [Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]
    Tidsskr Nor Laegeforen, 121 (16), 1902-7
    PubMed 11488180
  8. Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Lien E, Frøland SS, Aukrust P (2001)
    Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure
    Circulation, 103 (2), 220-5
    PubMed 11208680
  9. Helle SI, Ueland T, Ekse D, Frøland SS, Holly JM, Lønning PE, Aukrust P (2001)
    The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapy
    J Clin Endocrinol Metab, 86 (1), 227-33
    PubMed 11232005
  10. Holm T, Andreassen AK, Ueland T, Kjekshus J, Frøland SS, Kjekshus E, Simonsen S, Aukrust P, Gullestad L (2001)
    Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients
    Am J Cardiol, 87 (6), 815-8, A9
    PubMed 11249916
  11. Holm T, Berge RK, Andreassen AK, Ueland T, Kjekshus J, Simonsen S, Frøland S, Gullestad L, Aukrust P (2001)
    Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients
    Transplantation, 72 (4), 706-11
    PubMed 11544435
  12. Mellembakken JR, Aukrust P, Hestdal K, Ueland T, Abyholm T, Videm V (2001)
    Chemokines and leukocyte activation in the fetal circulation during preeclampsia
    Hypertension, 38 (3), 394-8
    PubMed 11566911
  13. Mellembakken JR, Solum NO, Ueland T, Videm V, Aukrust P (2001)
    Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia--possible role of platelet activation
    Thromb Haemost, 86 (5), 1272-6
    PubMed 11816717
  14. Schafroth U, Godang K, Ueland T, Bollerslev J (2001)
    Leptin response to endogenous acute stress is independent of pituitary function
    Eur J Endocrinol, 145 (3), 295-301
    PubMed 11517010
  15. Ueland T, Bollerslev J, Godang K, Müller F, Frøland SS, Aukrust P (2001)
    Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis
    Eur J Endocrinol, 145 (6), 685-90
    PubMed 11720891
  16. Ueland T, Frøland SS, Bollerslev J, Aukrust P (2001)
    Increased levels of biochemical markers of bone turnover in relation to persistent immune activation in common variable immunodeficiency
    Eur J Clin Invest, 31 (1), 72-8
    PubMed 11168441

Publications 2000

  1. Aukrust P, Bjørnsen S, Lunden B, Otterdal K, Ng EC, Ameln W, Ueland T, Müller F, Solum NO, Brosstad F, Frøland SS (2000)
    Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy
    Thromb Haemost, 84 (2), 183-7
    PubMed 10959687
  2. Aukrust P, Müller F, Ueland T, Svardal AM, Berge RK, Frøland SS (2000)
    Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses
    Eur J Clin Invest, 30 (3), 252-9
    PubMed 10692003
  3. Bollerslev J, Ueland T, Landaas S, Marks SC (2000)
    Serum creatine kinase isoenzyme BB in mammalian osteopetrosis
    Clin. Orthop. Rel. Res. (377), 241-247
  4. Bollerslev J, Ueland T, Landaas S, Marks SC (2000)
    Serum creatine kinase isoenzyme BB in mammalian osteopetrosis
    Clin Orthop Relat Res (377), 241-7
    PubMed 10943208
  5. Damås JK, Eiken HG, Oie E, Bjerkeli V, Yndestad A, Ueland T, Tonnessen T, Geiran OR, Aass H, Simonsen S, Christensen G, Froland SS, Attramadal H, Gullestad L, Aukrust P (2000)
    Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
    Cardiovasc Res, 47 (4), 778-87
    PubMed 10974226
  6. Damås JK, Gullestad L, Ueland T, Solum NO, Simonsen S, Frøland SS, Aukrust P (2000)
    CXC-chemokines, a new group of cytokines in congestive heart failure--possible role of platelets and monocytes
    Cardiovasc Res, 45 (2), 428-36
    PubMed 10728363
  7. Holm T, Aukrust P, Andreassen AK, Ueland T, Brosstad F, Frøland SS, Simonsen S, Gullestad L (2000)
    Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines
    Clin Transplant, 14 (3), 218-25
    PubMed 10831080
  8. Jacobsen MB, Aukrust P, Kittang E, Müller F, Ueland T, Bratlie J, Bjerkeli V, Vatn MH (2000)
    Relation between food provocation and systemic immune activation in patients with food intolerance
    Lancet, 356 (9227), 400-1
    PubMed 10972377
  9. Schafroth U, Godang K, Ueland T, Berg JP, Bollerslev J (2000)
    Leptin levels in relation to body composition and insulin concentration in patients with endogenous Cushing's syndrome compared to controls matched for body mass index
    J Endocrinol Invest, 23 (6), 349-55
    PubMed 10908161
  10. Schafroth U, Godang K, Ueland T, Berg JP, Bollerslev J (2000)
    Leptin revels in relation to body composition and insulin concentration in patients with endogenous Cushing's syndrome compared to controls matched for body mass index
    J. Endocrinol. Invest., 23 (6), 349-355

Publications 1999

  1. Aukrust P, Haug CJ, Ueland T, Lien E, Müller F, Espevik T, Bollerslev J, Frøland SS (1999)
    Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy
    J Clin Endocrinol Metab, 84 (1), 145-50
    PubMed 9920075
  2. Aukrust P, Müller F, Ueland T, Berget T, Aaser E, Brunsvig A, Solum NO, Forfang K, Frøland SS, Gullestad L (1999)
    Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
    Circulation, 100 (6), 614-20
    PubMed 10441098
  3. Aukrust P, Ueland T, Lien E, Bendtzen K, Müller F, Andreassen AK, Nordøy I, Aass H, Espevik T, Simonsen S, Frøland SS, Gullestad L (1999)
    Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
    Am J Cardiol, 83 (3), 376-82
    PubMed 10072227
  4. Godang K, Ueland T, Bollerslev J (1999)
    Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing's syndrome
    Eur J Endocrinol, 141 (2), 126-31
    PubMed 10427155
  5. Gullestad L, Aukrust P, Ueland T, Espevik T, Yee G, Vagelos R, Frøland SS, Fowler M (1999)
    Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
    J Am Coll Cardiol, 34 (7), 2061-7
    PubMed 10588224
  6. Gullestad L, Simonsen S, Ueland T, Holm T, Aass H, Andreassen AK, Madsen S, Geiran O, Frøland SS, Aukrust P (1999)
    Possible role of proinflammatory cytokines in heart allograft coronary artery disease
    Am J Cardiol, 84 (9), 999-1003
    PubMed 10569653
  7. Ueland T, Bollerslev J, Hansen TB, Ebbesen EN, Mosekilde L, Brixen K, Flyvbjerg A, Djøseland O (1999)
    Increased cortical bone content of insulin-like growth factors in acromegalic patients
    J Clin Endocrinol Metab, 84 (1), 123-7
    PubMed 9920071

Publications 1998

  1. Andreassen AK, Nordøy I, Simonsen S, Ueland T, Müller F, Frøland SS, Gullestad L, Aukrust P (1998)
    Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation
    Am J Cardiol, 81 (5), 604-8
    PubMed 9514458
  2. Aukrust P, Ueland T, Müller F, Andreassen AK, Nordøy I, Aas H, Kjekshus J, Simonsen S, Frøland SS, Gullestad L (1998)
    Elevated circulating levels of C-C chemokines in patients with congestive heart failure
    Circulation, 97 (12), 1136-43
    PubMed 9537339
  3. Bollerslev J, Ueland T, Grodum E, Haug E, Brixen K, Djøseland O (1998)
    Biochemical markers of bone metabolism in benign human osteopetrosis: a study of two types at baseline and during stimulation with triiodothyronine
    Eur J Endocrinol, 139 (1), 29-35
    PubMed 9703375
  4. Gullestad L, Haywood G, Aass H, Ross H, Yee G, Ueland T, Geiran O, Kjekshus J, Simonsen S, Bishopric N, Fowler M (1998)
    Angiotensin II receptor subtype AT1 and AT2 expression after heart transplantation
    Cardiovasc Res, 38 (2), 340-7
    PubMed 9709394
  5. Gullestad L, Aass H, Ross H, Ueland T, Geiran O, Kjekshus J, Simonsen S, Fowler M, Kobilka B (1998)
    Neuropeptide Y receptor 1 (NPY-Y1) expression in human heart failure and heart transplantation
    J Auton Nerv Syst, 70 (1-2), 84-91
    PubMed 9686908
 
[175 visits]
>> Go back   >> Print this page   >> E-mail this page